Skip to main content
Livermore
Livermore
ZHEN

Bokf, NA

SEC CIK
0000009634
Latest filing
Aug 10, 2026

NBIX holding history

Neurocrine Biosciences Inc in every 13F filed by Bokf, NA, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NBIX overviewAll 13F holders of NBIXFull Q2 2026 holdings

Shares (Q2 2026)
2,112
Value
$355.9K
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of NBIX by Bokf, NA, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20262,112$355.9K<0.1%−81−3.7%ReducedHolders
Q1 20262,193$288.9K<0.1%+27+1.2%AddedHolders
Q4 20252,166$307.2K<0.1%−434−16.7%ReducedHolders
Q3 20252,600$365.0K<0.1%−13−0.5%ReducedHolders
Q2 20252,613$328.4K<0.1%−3,706−58.6%ReducedHolders
Q1 20256,319$698.9K<0.1%+2,287+56.7%AddedHolders
Q4 20244,032$568.1K<0.1%+13+0.3%AddedHolders
Q3 20244,019$449.6K<0.1%+11+0.3%AddedHolders
Q2 20244,008$551.8K<0.1%−23−0.6%ReducedHolders
Q1 20244,031$569.9K<0.1%+25+0.6%AddedHolders
Q4 20234,006$527.8K<0.1%+27+0.7%AddedHolders
Q3 20233,979$441.4K<0.1%−459−10.3%ReducedHolders
Q2 20234,438$418.5K<0.1%−252−5.4%ReducedHolders
Q1 20234,690$474.7K<0.1%−367−7.3%ReducedHolders
Q4 20225,057$604.0K<0.1%+264+5.5%AddedHolders
Q3 20224,793$509.0K<0.1%−76−1.6%ReducedHolders
Q2 20224,869$475.0K<0.1%+71+1.5%AddedHolders
Q1 20224,798$450.0K<0.1%+157+3.4%AddedHolders
Q4 20214,641$395.0K<0.1%−851−15.5%ReducedHolders
Q3 20215,492$527.0K<0.1%–No prior filingHolders
Q2 2021––––Not filedHolders
Q1 202120,208$1.97M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.